Praxis Precision Medicines (PRAX) Total Current Liabilities (2019 - 2026)

Praxis Precision Medicines has reported Total Current Liabilities for 8 years, with the latest figure at $50.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 27.12% year-over-year to $50.2 million; the trailing twelve-month figure through Mar 2026 stood at $50.2 million (up 27.12% YoY), and the FY2025 full-year result was $59.8 million, up 59.18% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $50.2 million, down from $59.8 million in the prior quarter.
• The five-year high for Total Current Liabilities was $59.8 million in Q4 2025, with the low at $15.7 million in Q4 2023.
• Average Total Current Liabilities over 5 years is $35.0 million, with a median of $34.3 million recorded in 2022.
• Year-over-year, Total Current Liabilities soared 229.18% in 2022 and slumped 54.14% in 2023.
• Tracing PRAX's Total Current Liabilities over 5 years: stood at $34.3 million in 2022, then tumbled by 54.14% to $15.7 million in 2023, then soared by 138.43% to $37.6 million in 2024, then soared by 59.18% to $59.8 million in 2025, then dropped by 15.94% to $50.2 million in 2026.
• The last three Total Current Liabilities figures came in at $50.2 million (Q1 2026), $59.8 million (Q4 2025), and $52.9 million (Q3 2025), per Business Quant data.

Peer Comparison